AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+13.9%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.06B
AUM Growth
+$2.06B
(-5.4%)
Cap. Flow
+$28.8M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
62.6%
Holding
111
New
10
Increased
20
Reduced
15
Closed
11
Top Buys
Top Sells
| 1 |
NVIDIA
NVDA
|
$38.3M |
| 2 |
Avantor
AVTR
|
$14.7M |
| 3 |
Huazhu Hotels Group
HTHT
|
$12.7M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$11M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$11M |
Sector Composition
| 1 | Healthcare | 59.61% |
| 2 | Consumer Discretionary | 31.67% |
| 3 | Technology | 3.51% |
| 4 | Communication Services | 1.1% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $560M | 22.47% | 14,818,300 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $181M | 7.27% | 60,240,864 | – | – |
|
|
3
Avantor
AVTR
$9.18B
| $88.2M | 3.54% | 6,000,000 -1,000,000 | -14% | -$14.7M |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $79.6M | 3.19% | 650,000 | – | – |
|
5
Alibaba
BABA
$322B
| $75.3M | 3.02% | 450,000 | – | – |
|
6
Moderna
MRNA
$9.37B
| $73.3M | 2.94% | 4,606,298 | – | – |
|
|
MDCO
7
DELISTED
Medicines Co
MDCO
| $70M | 2.81% | 1,400,000 +400,000 | +40% | +$20M |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $59.3M | 2.38% | 1,500,000 | – | – |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $56.3M | 2.26% | 700,000 +300,000 | +75% | +$24.1M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $44.1M | 1.77% | 600,000 -150,000 | -20% | -$11M |
|
|
11
NVIDIA
NVDA
$4.24T
| $34.8M | 1.4% | 200,000 -220,000 | -52% | -$38.3M |
|
|
MORF
12
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $32.9M | 1.32% | 1,819,186 +1,319,186 | +264% | +$23.9M |
|
13
Fate Therapeutics
FATE
$120M
| $31.1M | 1.25% | 2,000,000 +500,000 | +33% | +$7.77M |
|
14
Gossamer Bio
GOSS
$562M
| $27M | 1.08% | 1,608,968 | – | – |
|
15
argenx
ARGX
$43.6B
| $22.8M | 0.91% | 200,000 -20,000 | -9% | -$2.28M |
|
|
RUBY
16
DELISTED
Rubius Therapeutics, Inc
RUBY
| $22.2M | 0.89% | 2,833,791 | – | – |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $21.2M | 0.85% | 1,500,000 +350,000 | +30% | +$4.94M |
|
|
SAGE
18
DELISTED
Sage Therapeutics
SAGE
| $21M | 0.84% | 150,000 | – | – |
|
19
Scholar Rock
SRRK
$3.14B
| $21M | 0.84% | 2,346,040 | – | – |
|
20
Amicus Therapeutics
FOLD
$2.34B
| $20.1M | 0.8% | 2,500,000 | – | – |
|
21
Zillow
Z
$20.4B
| $19.4M | 0.78% | 650,000 -350,000 | -35% | -$10.4M |
|
22
Solid Biosciences
SLDB
$427M
| $17.6M | 0.7% | 1,700,000 +500,000 | +42% | +$5.17M |
|
|
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17M | 0.68% | +350,000 | New | +$17M |
|
|
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $17M | 0.68% | +500,000 | New | +$17M |
|
25
Cyclerion Therapeutics
CYCN
$7.91M
| $16.5M | 0.66% | 1,361,584 | – | – |
|